Brazil vs Vietnam: Cause of death, by non-communicable diseases, ages 0-4, female
Brazil
31.9%
in 2021
Vietnam
31.0%
in 2021
Brazil rank
88th
Vietnam rank
89th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Brazil
- Vietnam
How they compare
Brazil currently reports 31.9% against 31.0% in Vietnam, a difference of 0.9%.
Across all 6 years both countries report, Brazil has been ahead every year.
Brazil ranks 88th and Vietnam ranks 89th of 185 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Vietnam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.3% | 18.9% | 2.4% | Brazil |
| 2010s | 31.4% | 28.8% | 2.6% | Brazil |
| 2020s | 31.9% | 30.5% | 1.4% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Brazil or Vietnam?
- Brazil, at 31.9% against 31.0% in Vietnam as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Brazil and Vietnam?
- 0.9%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Vietnam?
- 6 years are reported by both, from 2000 to 2021.
- How do Brazil and Vietnam rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Brazil ranks 88th and Vietnam ranks 89th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.